Search Press releases Keywords From To 10 Nov 2022 Bimekizumab Demonstrated Sustained Clinical Responses to Week 52 in Phase 3 Studies in Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Read More 8 Nov 2022 UCB Reinforces Commitment to Rheumatology with 15 Abstracts including New Late-Breaking Data at ACR Convergence 2022 Read More 13 Oct 2022 UCB announces positive preliminary results for major brivaracetam (Briviact[®]) study in Asia Read More 27 Sep 2022 FINTEPLA[®▼] (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet Syndrome Read More 23 Sep 2022 Disposal of own shares Read More 22 Sep 2022 UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting Read More Pagination First page Previous page Previous … Page 38 Page 39 Page 40 Page 41 Current page 42 Page 43 Page 44 Page 45 Page 46 … Page 42 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
